publication date: Oct. 16, 2020
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.
Over the next two years, as president of the Association of American Cancer Institutes, Karen Knudsen will challenge her colleagues at North America’s premier cancer centers to focus on reducing cancer disparities.
NCI plans to mark the 50th anniversary of the National Cancer Act of 1971 with an effort to build a coalition of support for cancer research, including raising the payline to 15% by 2025.
The global coronavirus pandemic has torn the veil that dimmed the nation’s awareness of the breadth and depth of health disparities, including cancer health disparities.
A cancer pioneer, Helene G. Brown had coined the name for her peculiar subspecialty: political oncology.
- OSUCCC – James receives $7 million Program Project NCI grant renewal
- Walther Cancer Foundation to invest $11 million to expand IU-Purdue bioinformatics collaboration
- John Glaspy named inaugural chair in integrative oncology at UCLA
- SKCC refines NCI-supported research programs
Researchers from Icahn School of Medicine at Mount Sinai was recently awarded a U54 grant ($3.9 million over the first two years as a part of a five-year research proposal) to establish a NCI/SeroNet Center for Serological Excellence at Mount Sinai with a focus on lung cancer.
- Genomic study of 6,000 NCI-MATCH cancer patients leads to new clinical trial benchmarks
- Miami Cancer Institute analysis shows developments for brain metastases patients
- Napo Pharmaceuticals initiates phase III trial of Mytesi for prophylaxis of diarrhea in adult cancer patients
- Phase II EV-201 study demonstrates 52% ORR in urothelial cancer
- Virus-mimicking drug helps immune system target cunning cancer cells
- Keytruda receives FDA approvals in Hodgkin lymphoma indications
- United Kingdom signs on to FDA’s Project Orbis
- MD Anderson and Allogene Therapeutics collaborate to advance allogeneic CAR T therapy